Meixatech, did Walbert give any hints as to the timeline for FDA approval at the SHM?
Question:
Why would IDM sell itself before anticipated approval later this year? Surely the company could command a much higher price in sale after approval. Of course maybe IDM management knows something we don't, like another delay on the approval decision, which would take us deep into 2009.
This along with Walbert taking other CEO job has me wondering what is going on right now.
RE: PPS on approval, my uneducated guess could see about +250% increase max. Thus if IDMI is at about $2.00, if and when approval comes, we could see a jump to about $7.00, plus or minus $1.00. Conversely, non-approval, or another delay, we could see <$1.00 again.
GLTA